Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 10.56
+0.50 (4.97%)
At close: Mar 6, 2026
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 4.02 billion as of March 6, 2026. Its market cap has increased by 40.24% in one year.
Market Cap
4.02B
Enterprise Value
3.95B
Revenue
2.69B
Ranking
n/a
PE Ratio
27.04
Stock Price
10.56
Market Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 4.02B, an increase of 122.45%. That is a compound annual growth rate of 4.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.02B | 18.12% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.34B |
| Zhejiang Shouxiangu Pharmaceutical | 4.31B |
| Hinova Pharmaceuticals | 4.01B |
| Zhejiang Wecome Pharmaceutical Company | 3.95B |
| Guanhao Biotech | 3.88B |
| Qingdao Vland Biotech INC. | 3.75B |
| Boji Medical Technology | 3.71B |
| Shanghai Shen Lian Biomedical | 3.63B |